Antimicrobial Resistance (AMR)
The WHO lists AMR in the top 10 global health threats but new antibiotic development is not keeping pace with the emergence of resistant pathogens. Novel ways to structure the market are being explored which incentivise developers and give healthcare systems new tools to fight AMR.
- October 2022
The Economics of Antibiotics – Part 1: Why NICE and NHS England are Testing an Innovative HTA and Payment Model to Tackle Antimicrobial Resistance
- Past Event
- Sponsored webinar
- September 2022
Can we “Netflix” the Broken Antibiotics Market?
- March 2020
How do we Get and Pay for New Antibiotics? Proposed New Models for Value Assessment and Contracting for Payment.
- October 2019
Patient Preferences for Diagnostic Tests Aimed at Managing Antimicrobial Resistance
- October 2017
Antimicrobials Resistance: A Call for Multi-disciplinary Action. How Can HTA Help? A Summary of a Symposium held at HTAi Rome 2017
- May 2017